Sanitas Radio | Because your health and longevity should not be classified information.

Monday, August 4, 2014

Natural Treatments for Ebola Virus Exist, Research Suggests

Coffee, fermented soy, homeopathic
spider venom and vitamin C, may all hold promise as anti-Ebola virus
therapies, despite the common belief that nothing can stop this lethal
virus from spreading uncontrollably worldwide.

Fear
of infection with the Ebola virus is becoming as contagious as the
virus itself, with mainstream media outlets like CNN reporting, 'Ebola
outbreak could have 'catastrophic' consequences.'

Given the
prevailing mortality statistics, perhaps the fear is, at least
partially, justified, with the most virulent form of the virus – the
Zaire Ebola virus – observed to have a fatality rate of about 83%,[1]
and with no officially recognized conventional or natural therapy found
capable of mitigating morbidity and mortality associated with infection
from it.

There are actually five Ebola viruses in the Ebolavirus
genus,[2] with four of them known to infect humans causing Ebola virus
disease, a highly lethal form of hemorrhagic fever. Ebola virus
infection is believed to originate from either monkeys or fruit bats,
and once a human is infected, transmission can occur through blood or
bodily fluids, sexual intercourse,[3] and as a recent concerning
investigative report revealed, through the air.

While the
conventional medical system reflexively puts its faith and money into
drug and vaccine development, with NIH recently announcing it will begin
an early trial on Ebola vaccines this September of this year, very
little research has been performed on reducing risk, or mitigating
post-infection harm, with the use of time-tested, natural
immune-boosting and/or plant-based approaches. Given the low safety risk
and cost of botanical- and food-based interventions, this is where we
should be looking first for viable, and immediately accessible
solutions. Indeed, a recent study published in 2012 holds great promise
as far as identifying a natural way to mitigate the virulence – and
therefore also widespread fear -- associated with Ebola virus.

Published
in the journal Archives of Virology and titled, "Inhibition of Lassa
virus and Ebola virus infection in host cells treated with the kinase
inhibitors genistein and tyrphostin," researchers at the University of
Texas Medical Branch, investigated the potential therapeutic role of two
so-called 'kinase inhibitors' in interfering with Ebola virus: 1) the
plant compound genistein 2) the pharmaceutical drug tyrophostin.

The
authors reference a previous animal study showing genistein was able to
reduce harm from infection from a virus that causes an Ebola-like viral
hemorrhagic fever (VHF) in hamsters (namely, Pichinde ́virus (PICV)),
reporting the results as follows: